Verition Fund Management LLC
Q4 2022 13F-HR Holdings
Net value change ($000)
-2,427,255
(-27.5%)
New positions
209
Sold out positions
866
Turnover %
45.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| USB | 43,981 | 391.8% |
| Horizon Therapeutics Public Ltd Co | 40,272 | 681.3% |
| VMWA | 36,780 | 341.0% |
| GFL | 35,739 | NEW |
| PCG | 31,816 | NEW |
| CACI | 28,445 | NEW |
| CMS | 20,215 | 163.0% |
| TDG | 20,128 | 1589.9% |
| PPL | 19,283 | 82.4% |
| VLY | 18,958 | 199.9% |
Top Reduces (Value $000, Stocks/ETFs)
| AVALARA, INC. | -73,702 | -100.0% |
| EEM | -52,231 | -100.0% |
| TERMINIX GLOBAL HOLDINGS INC | -52,076 | -100.0% |
| ALLEGHANY CORP /DE | -49,108 | -100.0% |
| FE | -45,923 | -91.1% |
| PCG | -43,720 | -63.3% |
| RIO | -37,641 | -100.0% |
| VST | -37,615 | -71.4% |
| LQD | -35,739 | -92.6% |
| AIY | -35,569 | -52.6% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,261,158
(19.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|